Printer-friendly versionPrinter-friendly version
General Information
The date when the cluster organisation was established: 
Thursday, 1 March, 2012
Number of staff in the management team of the cluster organisation : 
1-5
Regions: 
Nord-Est
Cluster Excellence Label: 
Bronze Label
Membership to other networks/partnerships: 
Cluster Management Team: 
NameSurnamePositionTelephoneEmail
Bogdan Ionel
Tamba
Cluster Manager
+40729290877
bogdan.tamba@umfiasi.ro
Languages spoken: 
English
French
Italian
Romanian
Spanish
Sectoral and Industrial Focus
Sectoral Industries: 
Biopharmaceuticals
Technology fields: 
Medical Research
Pharmaceutical Products / Drugs
S3 EU priority areas: 
Nanotechnology
Basic pharmaceutical products & pharmaceutical preparations
Emerging industries: 
Biopharmaceuticals
Medical Devices
Areas of specialisation of the cluster not covered above: 
bioinformatics, drug production, pharmacogenomics, gene therapy, genetic testing, nanotechnologies, bioengineering, health services, and human diagnosis, biopharmaceuticals and equipment manufacturers.
Composition of the cluster
Total number of members: 
17
Number of SME members: 
7
Number of larger company members: 
1
Number of research organisations/universities/technology centres: 
7
Number of other ecosystem actors : 
2
Entrepreneurship and scale-up support facilities in the cluster's ecosystem (see "Organisation type"): 
Name and link of major players: 
NameWebsiteType
Gr.T.Popa University of Medicine and Pharmacy Iasi
University
Alexandru Ioan Cuza University of Iași
University
St. Spiridon Clinical Emergeny Hospital
Research Organisation
Regional Oncology Institute
Research Organisation
Institute of Macromolecular Chemistry "Petru Poni" Iasi
Research Organisation
National Institute of Research and Development for Technical Physics
Research Organisation
SC Antibiotice SA
Larger Company
A&B Pharm Corporation
SME
Unic Pharmaceutical
SME
SC Plantavorel SRL
SME
SC Kober SRL
SME
SC Cromatech Plus SRL
SME
SC Ircon SRL
SME
Cluster Strategy
Mission/Objectives: 

bioROne aims to act as a network and common platform to help maximise the innovation potential of NE Romania, and strengthen the innovation process from an original idea to a product. This is the first such initiative in the field of biotechnologies both in Romania and in South-East Europe. 

Key objectives include:

  • Shift the innovation culture from education to economy

  • Explore and develop the high calibre human resource pool that exists in the region

  • Support successful collaborations between members of the clusters, as well as between the cluster and external partners (e.g. investors)

  • Move from small single-entity projects, to fewer large multi-partner projects, with higher eligibility for funding

  • Help with advise on finance opportunities and funding programs

  • Support entrepreneurial initiatives in the biotech space

  • Represent the region’s innovation hub at the international level

  • Attract new partners and investments to the region to create a CEE hub for innovation. 

In terms of research areas, bioROne is focused mainly on applications of bioinformatics, drug production, pharmacogenomics, gene therapy, genetic testing, nanotechnologies, bioengineering, health services, and human diagnosis, biopharmaceuticals and equipment manufacturers. 

Do you have a formalised strategy?: 
No
Do you have a specific strategy focus that addresses internationalisation ?: 
No
Services
Support services provided: 
Access to public support (regional/national programmes, innovation vouchers, etc.)
Facilitation of collaboration between members
Enabling Facilities sharing
Trend-scouting (Ideas for innovative projects)
Promotion of activities (marketing/ visibility)
Cooperation Activities
International Cooperation
The main countries targeted by the cluster organisation: 
China
Japan
United States
Our cluster organisation undertook the following international activities to support our members: 
Participation at missions/events/study visits/fairs
Trans-national Cooperation
The main countries targeted by the cluster organisation: 
Belgium
Germany
Hungary
Italy
Spain
Our cluster organisation undertook the following trans-national activities to support our members: 
Participation at missions/events/study visits/fairs
Which clusters do you collaborate with?: 
Imago-Mol
Support Programmes
Participation in Funded Support Programmes: 
European Programmes
FP7
H2020
INTERREG
Other
Promotion
Success Story / Achievements: 
  • Strategic partnership with CIMIT (Cambridge, USA) www.cimit.org 

Why should partners choose you for cooperation?: 
  • bioROne cluster can flourish by building a competitive advantage as a low-cost provider of research and development and manufacturing.  
  • 2 universities, 2 research institutes, 3 clinical hospitals, and the largest Romanian-owned pharmaceutical company (generics)
  • A community of more than 500 professionals from academia, industry, government, with international education and experience in US, Europe and Asia
  • Extensive, proven R&D experience: over 50 years of activity, over 100 patents, more than 100 research contracts and grants in last 5 years with a cumulative value of over €50M (cumulative)